Cannabidiol in Alzheimer's disease: evidence-weighted molecular mechanisms and translational challenges.

Sreenivasulu Sura; Saravanan Jagadeesan; Siti Saleha Masrudin; Mohamad Aris Mohd Moklas; Nurul Huda Mohd Nor

doi:10.1007/s11033-026-13034-9

SCHEDA SCIENTIFICA2026Altra ricerca

Cannabidiol in Alzheimer's disease: evidence-weighted molecular mechanisms and translational challenges.

Sreenivasulu Sura, Saravanan Jagadeesan, Siti Saleha Masrudin, Mohamad Aris Mohd Moklas, Nurul Huda Mohd Nor

Molecular biology reports · 2026

Psicologia clinica Psicoterapia Psicologia cognitiva

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

Alzheimer DiseaseHumansCannabidiolAnimalsOxidative StressAmyloid beta-PeptidesSignal TransductionAlzheimer’s diseaseMitochondrial dysfunctionNeuroinflammationOxidative stressSynaptic plasticity

Come citare questo studio

Sreenivasulu Sura, Saravanan Jagadeesan, Siti Saleha Masrudin, Mohamad Aris Mohd Moklas, Nurul Huda Mohd Nor. (2026). Cannabidiol in Alzheimer's disease: evidence-weighted molecular mechanisms and translational challenges.. Molecular biology reports. DOI: 10.1007/s11033-026-13034-9

Consulta la pubblicazione originale ↗